|
|
Article: Prometheus Laboratories Obtains Exclusive License to Genetic Technology for Lactose Intolerance.
- Article from:
- PR Newswire
- Article date:
- October 10, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN DIEGO -- Prometheus Laboratories Inc. announced today that it has signed a license agreement for intellectual property related to two highly sensitive and specific DNA variations to a gene associated with adult-type hypolactasia (lactose intolerance), with the National Public Health Institute, Finland. The agreement covers any and all applications of this technology, and is exclusive worldwide with the exception of Finland, the Baltic States and Russia where it is non-exclusive. The agreement also includes a continuing research collaboration.
Current diagnostic methods for assessing lactose intolerance, such as the lactose tolerance test and the breath ...